Back to Market Feed

VRAYLAR 3 MG CAPSULE

cariprazine
$50.9560per EA

Strength

3 mg/1

Manufacturer

Allergan, Inc.

NDC

61874013030

Classification

Brand

Dosage Form

CAPSULE, GELATIN COATED

Route

ORAL

Last Updated

1/2/2026

Active Ingredients

CARIPRAZINE

Approval Type

New Drug (NDA)

FDA Application

NDA204370

On Market Since

9/17/2015

Pharmacological Classes

Atypical Antipsychotic

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.0%

1Y

+4.9%

3Y

+15.7%

5Y

+25.9%

All

+57.1%

Generic Alternatives

1 alternative • Same active ingredient

VRAYLAR 3 MG CAPSULE
Brand
61874013020•Allergan, Inc.
$50.9560

Related Drugs

Same classification

SEROQUEL 25 MG TABLET
Brand
00310027510•AstraZeneca Pharmaceuticals LP
$3.7050
per EA
RISPERDAL 0.5 MG TABLET
Brand
50458030201•Janssen Pharmaceuticals Inc.
$4.3928
per EA
RISPERDAL 0.5 MG TABLET
Brand
50458030206•Janssen Pharmaceuticals Inc.
$4.3928
per EA
RISPERDAL 1 MG TABLET
Brand
50458030001•Janssen Pharmaceuticals Inc.
$4.6958
per EA
RISPERDAL 1 MG TABLET
Brand
50458030006•Janssen Pharmaceuticals Inc.
$4.6958
per EA
RISPERDAL 1 MG/ML SOLUTION
Brand
50458030503•Janssen Pharmaceuticals Inc.
$5.2507
per ML
SEROQUEL 50 MG TABLET
Brand
00310027810•AstraZeneca Pharmaceuticals LP
$6.0917
per EA
CLOZARIL 25 MG TABLET
Brand
69809012605•HLS Therapeutics (USA), Inc.
$6.2959
per EA
SEROQUEL 100 MG TABLET
Brand
00310027110•AstraZeneca Pharmaceuticals LP
$6.3802
per EA
SEROQUEL XR 50 MG TABLET
Brand
00310028060•AstraZeneca Pharmaceuticals LP
$7.7675
per EA